8.39

1.06% -0.09

After Hours: 8.39

Haleon plc ADR (HLN)

Overview News Price History Option Chain Discussions Forecast Dividend History

Haleon plc ADR stock is currently priced at $8.39, with a 24-hour trading volume of 2.52M. It has seen a -1.06% decreased in the last 24 hours and a +0.84% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $8.45 pivot point. If it approaches the $8.38 support level, significant changes may occur.

Previous Close:

$8.48

Open:

$8.33

24h Volume:

2.52M

Market Cap:

$38.31B

Revenue:

$14.13B

Net Income/Loss:

$1.37B

P/E Ratio:

25.22

EPS:

0.3327

Net Cash Flow:

1W Performance:

-1.53%

1M Performance:

+0.84%

6M Performance:

+2.82%

1Y Performance:

+2.19%

1D Range:

$8.32

$8.41

52W Range:

$7.695

$8.96

Haleon plc ADR Stock (HLN) Company Profile

Name

Haleon plc ADR

Sector

Healthcare (1204)

Industry

Drug Manufacturers - Specialty & Generic (2)

Phone

44 1932 822000

Address

Building 5, First Floor The Heights, Weybridge

Employee

22,800

Twitter

Next Earnings Date

Latest SEC Filings

HLN's Discussions on Twitter

Haleon plc ADR Stock (HLN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-11-23	Resumed	Jefferies	Buy
Nov-01-23	Initiated	Morgan Stanley	Overweight
May-24-23	Initiated	Stifel	Hold
Apr-06-23	Upgrade	Argus	Hold → Buy
Apr-04-23	Initiated	Bernstein	Outperform
Dec-07-22	Upgrade	Barclays	Equal Weight → Overweight
Sep-28-22	Initiated	Argus	Hold

View All

Haleon plc ADR Stock (HLN) Latest News

Choosing between riding the trend or protecting profits: Haleon plc ADR (HLN) – US Post News - US Post News

US Post News

Pfizer: Headwinds Dissipating, New Obesity Pipeline Update Coming Soon

Seeking Alpha

HLN’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

The InvestChronicle

Financial Snapshot: Analyzing Haleon plc ADR (HLN)'s Key Ratio Metrics – DWinneX - The Dwinnex

The Dwinnex

Taking on analysts' expectations and winning: Haleon plc ADR (HLN) – Sete News - SETE News

SETE News

Haleon plc ADR (HLN) Stock: A Year of Stock Market Dynamics - The InvestChronicle

The InvestChronicle

Haleon plc ADR Stock (HLN) Financials Data

Haleon plc ADR (HLN) Revenue 2024

HLN reported a revenue (TTM) of $14.13 billion for the quarter ending March 31, 2024, a -3.99% decline year-over-year.

Haleon plc ADR (HLN) Net Income 2024

HLN net income (TTM) was $1.37 billion for the quarter ending March 31, 2024, a +2.82% increase year-over-year.

Haleon plc ADR (HLN) Earnings per Share 2024

HLN earnings per share (TTM) was $0.2969 for the quarter ending March 31, 2024, a +3.16% growth year-over-year.

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.